Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

Market Cap	6.10B
Revenue (ttm)	1.06B
Net Income (ttm)	134.23M
Shares Out	109.28M
EPS (ttm)	1.20
PE Ratio	46.60
Forward PE	n/a
Dividend	0.16 (0.29%)
Ex-Dividend Date	n/a

Volume	9,661,956
Average Volume	4,267,650
Open	53.10
Previous Close	53.10
Day's Range	52.30 - 59.98
52-Week Range	28.90 - 59.98
Beta	0.22
RSI	70.81
Earnings Date	Aug 29, 2025

About SHA:688621

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and o...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2009
• Employees: 1,556
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688621

Financial Performance

In 2024, SHA:688621's revenue was 1.08 billion, an increase of 15.70% compared to the previous year's 932.12 million. Earnings were 177.41 million, a decrease of -3.98%.